GLP-1 receptor agonists—including well-known brand names like Ozempic, Wegovy, and Zepbound—have transformed weight management and metabolic health. As prescribing rates rise rapidly across the country, insurance advisors frequently encounter clients taking these medications.
In Episode #5 of the Ask the Doctor series by Fortify Insurance Group, host Courtney Wilson speaks with in-house medical consultant Dr. Chelsea Alvarado to break down how carriers evaluate GLP-1 treatments during life, disability, and long-term care (LTC) underwriting.
Watch now »